Skip to main content

Table 1 Demographic and clinical characteristics of patients involved in the study

From: A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

Subjects HD BPH/Prostatitis Prostate Cancer
  n = 124 n = 121 n = 131
Age (year)    
unknown 124 2 4
<40   2 1
40-49   4 2
50-59   16 2
60-69   30 14
70-79   46 38
>80   21 20
Collection site*    
Japan 84 121 81
U.S. 40 0 50
Gleason Scores    
unknown    10
< and = 6    61
7    29
> and = 8    31
  1. *Race is not known, samples are only classified based on the collection site. Note that this pilot study is focused on comparing A+PSA with the PSA assay, cohort size was not sufficient to match samples according to potential clinical co-founders.